Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 28,456

Document Document Title
WO/2015/002208A1
A compound characterized by being represented by general formula (1). In general formula (1), n is 1 or 2. Ar1 is represented by general formula (2). Ar2 is a substituted or un-substituted aromatic hydrocarbon group having 6-30 carbons, ...  
WO/2015/000412A1
The present invention relates to a benzocyclobutene derivative and a preparation method and pharmaceutical application thereof. Specifically, the present invention relates to a compound expressed by formula (I) or a stereoisomer, hydrate...  
WO/2014/205592A1
Compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV in...  
WO/2014/207764A1
An efficient, hydrogen gas-free, high yielding, moderate temperature and safe-to-handle process for producing furan and its derivatives from furfural, which comprises contacting furfural and water-isopropanol mixture with a supported Pd ...  
WO/2014/205593A1
Disclosed are compounds of formula (I) that are useful as hepatitis C virus (HCV) NSSB polymerise inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NSSB polymerise activity, for treating or pre...  
WO/2014/208132A1
Provided are: a compound that contains a phenolic hydroxyl group and that has superior thermal resistance and flame resistance of the cured product thereof; a phenolic resin containing the compound that contains a phenolic hydroxyl group...  
WO/2014/209112A1
The invention is directed to a process for the preparation of 2,5- furandicarboxylic acid (FDCA) by fermentation comprising fermenting a suitable starting compound to produce an aqueous solution of a salt of FDCA having a pH of at least ...  
WO/2014/203541A1
The purpose of the present invention is to provide an organic EL element which has a long service life, while achieving a lower driving voltage. An aromatic amine derivative according to the present invention is represented by formula (1...  
WO/2014/204175A1
The present invention relates to a crystalline form of (2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)benzofuran) and a method for preparing the same. The crystalline form of (2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)benzofuran) according...  
WO/2014/203058A1
The present invention relates to a process for preparing Dronedarone or its pharmaceutically acceptable salts thereof, by reacting 5-amino-3-[4-(3-di-n-butyl aminopropoxy)benzoyl]-2-n-butyl benzofuran or a salt thereof with methanesulfon...  
WO/2014/199306A3
A process is described for the preparation of 5-hydroxymethylfurfural (HMF), which comprises the following steps: provision or preparation of a starting mixture, comprising one, two or more starting compounds selected from the group cons...  
WO/2014/197991A1
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...  
WO/2014/198123A1
The present invention relates to the field of natural pharmaceutical chemistry, specifically to a resveratrol dimer, (7R, 8R)-trans-delta-viniferin (I), a preparation method therefor and the use thereof in reducing blood sugar. High-spee...  
WO/2014/197991A8
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...  
WO/2014/198057A1
Disclosed is a process for the production of furanic compound comprising at least one amine function, comprising reacting a furanic compound having at least one hydroxyl function or at least one aldehyde function with a second reactant h...  
WO/2014/196491A1
[Problem] To provide a method for producing a (2R)-2-fluoro-2-C-methyl-D-ribono-γ-lactone. [Solution] A 2-fluoro-2-halopropionic acid derivative and a D-glyceraldehyde derivative are subjected to a Reformatsky reaction using an activate...  
WO/2014/197514A1
The present disclosure generally relates to the production of fuels, gasoline additives, and/or lubricants, and precursors thereof. The compounds used to produce the fuels, gasoline additives, and/or lubricants, and precursors thereof ma...  
WO/2014/194957A1
The present invention relates to new compounds according to formula (I). Said compounds are particularly useful for the improvement of organic electronic devices where the compounds according to the present invention are used e.g. as dop...  
WO/2014/195972A1
A regioselective N-Heterocyclic Carbene (NHC) catalyzed one step process for high yield synthesis of α-acyloxy carbonyl compounds is disclosed.  
WO/2014/193635A1
Plasticizers comprising a dialkyl 2,5-furandicarboxylate and plasticized polymeric compositions comprising such plasticizers. Such plasticized polymeric compositions can be employed in forming various articles of manufacture, such as coa...  
WO/2014/194209A1
Disclosed herein are compounds having a formula: or a pharmaceutically acceptable salt thereof, as well as therapeutic methods, medicaments, and compositions related thereto.  
WO/2014/193033A1
The present invention relates to a compound, an organic light emitting element comprising the same, and a display device comprising the organic light emitting element. The present invention provides a compound for an organic optoelectron...  
WO/2014/192023A1
The present invention relates to compounds of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use ...  
WO/2014/194292A1
Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases o...  
WO/2014/187343A1
Disclosed are a benzofuran derivative, a preparation method therefor, and a medical application thereof, specifically relating to a compound represented by general formula (I), a stereoisomer thereof, a hydrate thereof, a solvate thereof...  
WO/2014/188762A1
The present invention is a radiation-sensitive resin composition which contains a polymer having a structural unit that contains an acid-cleavable group and a compound represented by formula (1). In formula (1), R1 represents a monovalen...  
WO/2014/188843A1
The purpose of the present invention is to provide a method for producing tetrahydrofuran with high reaction yield using erythritol that is a biomass or 3,4-dihydroxytetrahydrofuran that can be induced readily from erythritol as a raw ma...  
WO/2014/183211A1
Discloses is a process for preparation of a compound of formula 11, or a derivative thereof, wherein PG1 is an alcohol protecting group. Also, disclosed are intermediates and processes for their preparation. The compound of formula 11 ca...  
WO/2014/186035A1
The present application provides novel inhibitors of indoleamine 2,3-dioxygenase-1 and/or indoleamine 2,3-dioxygenase-2 and/or tryptophan 2,3-dioxygenase, metabolites thereof, and phannaceutically acceptable salts or prodrugs thereof. Al...  
WO/2014/184682A1
Provided herein is technology relating to imaging agents for positron emission tomography (PET) and particularly, but not exclusively, to a gonadotropin-releasing hormone (GnRH) antagonist radiolabeled with positron emitting nuclides and...  
WO/2014/184682A9
Provided herein is technology relating to imaging agents for positron emission tomography (PET) and particularly, but not exclusively, to a gonadotropin-releasing hormone (GnRH) antagonist radiolabeled with positron emitting nuclides and...  
WO/2014/182673A1
The present invention relates to compounds of Formula (la) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that modulate the activity of the Mas receptor, and are useful in methods of treatment and alleviation of d...  
WO/2014/180979A9
This invention relates to a new process for the synthesis of 5-hydroxymethylfurfural (HMF) from saccharides. In particular this invention relates to a new process for the dehydration of monosaccharides having 6 carbon atoms (hexoses), di...  
WO/2014/182873A1
The present disclosure provides novel furanone compounds, or pharmaceutically acceptable salts, solvates or prodrugs thereof, as Raf kinase, especially BRAF kinase, inhibitors, which are useful therapeutic agents for treatment of Raf kin...  
WO/2014/180271A1
Revealed in the present invention is a method for preparing Afatinib (I): using 2-nitrile-4-[4-(N,N-dimethylamino)-1-oxo-2-buten-1-yl]amino- 5-[(S)- (tetrahydrofuran-3-yl)oxy]aniline (II) and 4-fluoro-3-chloroaniline (III) as starting ma...  
WO/2014/180979A1
This invention relates to a new process for the synthesis of 5-hydroxymethylfurfural (HMF) from saccharides. In particular this invention relates to a new process for the dehydration of monosaccharides having 6 carbon atoms (hexoses), di...  
WO/2014/182244A1
The present invention provides a polymer comprising an aliphatic backbone having a plurality of aromatic rings bonded thereon, said plurality of aromatic rings comprising a first aromatic ring type that has an alkyl halide group substitu...  
WO/2014/182688A1
The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that modulate the activity of the Mas receptor, and are useful in methods of treatment and alleviation of d...  
WO/2014/182171A1
Disclosed is a method of making 5-formyl-2-furoic acid and furan- 2,5-dicarboxylic acid. The method involves the use of 5-keto-aldonic acids as intermediates, as these can be subjected to ring formation by a cyclodehydration reaction und...  
WO/2014/181788A1
The present invention provides: a novel α-substituted glycineamide derivative or a pharmacologically acceptable salt thereof; a pharmaceutical composition containing the α-substituted glycineamide derivative or a pharmacologically acce...  
WO/2014/177593A1
The present invention relates to Amorfrutin analogues and stereoisomeric forms, solvates, hydrates, conjugates and/or pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions containing at least one of ...  
WO/2014/179156A1
5-(hydroxymethyl) furan-2-carbaldehyde (HMF)-sulfonates and a method of preparing the same are described. The method involves reacting a mixture of 5-(hydroxymethyl)furfural (HMF), with at least one of a) a trifluoromethanesulfonate anhy...  
WO/2014/177464A3
The invention relates to inhibitors of the NHR2 tetramerization and their use as tumor therapeutics (e.g. against acute myeloid leukemia (AML)), cytostatics, and diagnostic agents.  
WO/2014/178381A1
 Provided is a new compound having glycogen synthase activation potency, but minimal activation of receptor PPAR, and a high degree of safety. A compound represented by general formula [I], or a pharmaceutically acceptable salt there...  
WO/2014/178389A1
Provided is a new compound having glycogen synthase activation potency, high muscular transition, minimal activation of receptor PPAR, and a high degree of safety. Provided is a compound represented by the following general formula, or a...  
WO/2014/175713A1
The present invention relates to a pharmaceutical composition comprising a 5-membered heterocyclic compound, having an analgesic effect, and a derivative thereof. More particularly, the present invention relates to a preparation method f...  
WO/2014/174416A3
A method of dehydration of at least one compound (A) comprising, in the chain form, -at least one hydroxyl group and -at least one carbonyl functionality selected from the group consisting of aldehyde (CHO), ke- tone (CO) and carboxylic ...  
WO/2014/176151A1
The present application relates to perfume delivery systems and consumer products comprising such perfume delivery systems, as well as processes for making and using such perfume delivery systems and consumer products. Such perfume deliv...  
WO/2014/173973A1
The invention provides a process for the preparation of monoethylene glycol from sucrose comprising the steps of: i) hydrolysing sucrose to form a reaction product stream comprising glucose and fructose; ii) separating the reaction produ...  
WO/2014/170909A3
The present invention provides a novel process for the preparation of pomalidomide crystalline Form I. The present invention also provides a process for the purification of pomalidomide.  

Matches 51 - 100 out of 28,456